Merck KGaA
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
12.89%
Market Cap
17.22 Bil.
P/E Ratio
20.44
Dividend Yield
1.79 %
Earnings per Share
6.00 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 135.25 G | 0 Units |
| PRICE DETERMINATION TIME | 06/04/2026 / 09:25:04 AM | |
| DAILY VOLUME (UNITS) | 675 | |
| DAILY HIGH / LOW | 135.35 | 133.05 |
| PREV. DAY'S PRICE | 133.25 | (06/03) |
| CHANGE DAY BEFORE | +2.00 | 1.50 % |
| 52 WEEK HIGH / LOW | 132.05 (06/01) | 100.65 (03/23) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 8.64 | 7.98 | 6.00 | 6.39 | 6.50 |
| DIVIDENDS PER SHARE | 2.35 | 2.28 | 2.20 | 2.20 | 2.20 |
| DIVIDEND YIELD IN % | - | - | 1.79 % | 1.57 % | 1.53 % |
| DIVIDEND GROWTH IN % | - | - | 0.00 % | 0.00 % | 0.00 % |
| PRICE - EARNINGS RATIO | 15.15 | 16.39 | 20.44 | 21.90 | 22.19 |
| PRICE - BOOK RATIO | - | - | 1.86 | 2.03 | 2.35 |
| PRICE - SALES RATIO | - | - | 2.53 | 2.88 | 2.98 |
| PRICE - CASH FLOW RATIO | - | - | 13.56 | 13.26 | 16.56 |
Master Data
| WKN | 659990 |
| ISIN | DE0006599905 |
| SYMBOL | MRK |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Merck |
| INDEX MEMBERSHIP | DAX |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | Euro |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | 129.24 Mil. |
| MARKET CAPITALISATION | 17.22 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 1.56 % | 17.75 % | 3.34 % | 10.17 % | 12.89 % | -21.96 % | -9.62 % | 6.34 % |
| HIGH | 132.05 | 132.05 | 132.05 | 132.05 | 132.05 | 176.90 | 231.50 | 132.05 |
| LOW | 127.65 | 108.45 | 100.65 | 100.65 | 100.65 | 100.65 | 100.65 | 100.65 |
Dividend
per share
Company profile
Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.
Structured products for Merck KGaA
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
(in 11 days)
06/15/26Roadshow
(in 13 days)
06/17/26Roadshow
(in 14 days)
06/18/26JP Morgan European Healthcare Forum
(in 19 days)
06/23/26Jefferies DACH Corporate Conference
(in 24 days)
06/28/26Atomic Layer Deposition International Conference